We also demonstrate that combining loss of function mutations in STK11/KEAP1/PTEN and activating ERBB2 exon 20 insertion mutations with pTMB improved the ability to predict response. Similar to previous reports[5], there was no correlation between pTMB and tumor PD-L1 expression.